Literature DB >> 32049047

The Repertoire of Serous Ovarian Cancer Non-genetic Heterogeneity Revealed by Single-Cell Sequencing of Normal Fallopian Tube Epithelial Cells.

Zhiyuan Hu1, Mara Artibani2, Abdulkhaliq Alsaadi3, Nina Wietek4, Matteo Morotti4, Tingyan Shi3, Zhe Zhong3, Laura Santana Gonzalez3, Salma El-Sahhar3, Mohammad KaramiNejadRanjbar3, Garry Mallett3, Yun Feng5, Kenta Masuda3, Yiyan Zheng3, Kay Chong3, Stephen Damato6, Sunanda Dhar6, Leticia Campo7, Riccardo Garruto Campanile8, Hooman Soleymani Majd8, Vikram Rai9, David Maldonado-Perez10, Stephanie Jones11, Vincenzo Cerundolo12, Tatjana Sauka-Spengler13, Christopher Yau14, Ahmed Ashour Ahmed15.   

Abstract

The inter-differentiation between cell states promotes cancer cell survival under stress and fosters non-genetic heterogeneity (NGH). NGH is, therefore, a surrogate of tumor resilience but its quantification is confounded by genetic heterogeneity. Here we show that NGH in serous ovarian cancer (SOC) can be accurately measured when informed by the molecular signatures of the normal fallopian tube epithelium (FTE) cells, the cells of origin of SOC. Surveying the transcriptomes of ∼6,000 FTE cells, predominantly from non-ovarian cancer patients, identified 6 FTE subtypes. We used subtype signatures to deconvolute SOC expression data and found substantial intra-tumor NGH. Importantly, NGH-based stratification of ∼1,700 tumors robustly correlated with survival. Our findings lay the foundation for accurate prognostic and therapeutic stratification of SOC.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fallopian tube; non-genetic heterogeneity; ovarian cancer; single-cell RNA sequencing

Mesh:

Year:  2020        PMID: 32049047     DOI: 10.1016/j.ccell.2020.01.003

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  37 in total

1.  A single-cell landscape of high-grade serous ovarian cancer.

Authors:  Benjamin Izar; Itay Tirosh; Elizabeth H Stover; Isaac Wakiro; Michael S Cuoco; Idan Alter; Christopher Rodman; Rachel Leeson; Mei-Ju Su; Parin Shah; Marcin Iwanicki; Sarah R Walker; Abhay Kanodia; Johannes C Melms; Shaolin Mei; Jia-Ren Lin; Caroline B M Porter; Michal Slyper; Julia Waldman; Livnat Jerby-Arnon; Orr Ashenberg; Titus J Brinker; Caitlin Mills; Meri Rogava; Sébastien Vigneau; Peter K Sorger; Levi A Garraway; Panagiotis A Konstantinopoulos; Joyce F Liu; Ursula Matulonis; Bruce E Johnson; Orit Rozenblatt-Rosen; Asaf Rotem; Aviv Regev
Journal:  Nat Med       Date:  2020-06-22       Impact factor: 53.440

Review 2.  Deciphering functional tumor states at single-cell resolution.

Authors:  Rolando Vegliante; Ievgenia Pastushenko; Cédric Blanpain
Journal:  EMBO J       Date:  2021-12-17       Impact factor: 11.598

3.  Cancer cell states recur across tumor types and form specific interactions with the tumor microenvironment.

Authors:  Dalia Barkley; Reuben Moncada; Maayan Pour; Deborah A Liberman; Ian Dryg; Gregor Werba; Wei Wang; Maayan Baron; Anjali Rao; Bo Xia; Gustavo S França; Alejandro Weil; Deborah F Delair; Cristina Hajdu; Amanda W Lund; Iman Osman; Itai Yanai
Journal:  Nat Genet       Date:  2022-08-05       Impact factor: 41.307

Review 4.  Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated.

Authors:  Keywan Mortezaee; Jamal Majidpoor; Ebrahim Kharazinejad
Journal:  Med Oncol       Date:  2022-09-07       Impact factor: 3.738

5.  Prognostic Significance of Lineage Diversity in Bladder Cancer Revealed by Single-Cell Sequencing.

Authors:  Lu Yu; Rixin Hu; Guoyu Peng; Qiuxia Ding; Tao Tao; Song Wu
Journal:  Front Genet       Date:  2022-05-19       Impact factor: 4.772

Review 6.  Promises and challenges of adoptive T-cell therapies for solid tumours.

Authors:  Matteo Morotti; Ashwag Albukhari; Abdulkhaliq Alsaadi; Mara Artibani; James D Brenton; Stuart M Curbishley; Tao Dong; Michael L Dustin; Zhiyuan Hu; Nicholas McGranahan; Martin L Miller; Laura Santana-Gonzalez; Leonard W Seymour; Tingyan Shi; Peter Van Loo; Christopher Yau; Helen White; Nina Wietek; David N Church; David C Wedge; Ahmed A Ahmed
Journal:  Br J Cancer       Date:  2021-03-29       Impact factor: 7.640

7.  Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor-initiating cells.

Authors:  Mara Artibani; Kenta Masuda; Zhiyuan Hu; Pascal C Rauher; Garry Mallett; Nina Wietek; Matteo Morotti; Kay Chong; Mohammad KaramiNejadRanjbar; Christos E Zois; Sunanda Dhar; Salma El-Sahhar; Leticia Campo; Sarah P Blagden; Stephen Damato; Pubudu N Pathiraja; Shibani Nicum; Fergus Gleeson; Alexandros Laios; Abdulkhaliq Alsaadi; Laura Santana Gonzalez; Takeshi Motohara; Ashwag Albukhari; Zhen Lu; Robert C Bast; Adrian L Harris; Christer S Ejsing; Robin W Klemm; Christopher Yau; Tatjana Sauka-Spengler; Ahmed Ashour Ahmed
Journal:  JCI Insight       Date:  2021-06-08

Review 8.  Mechanistic Drivers of Müllerian Duct Development and Differentiation Into the Oviduct.

Authors:  Laura Santana Gonzalez; Ioanna A Rota; Mara Artibani; Matteo Morotti; Zhiyuan Hu; Nina Wietek; Abdulkhaliq Alsaadi; Ashwag Albukhari; Tatjana Sauka-Spengler; Ahmed A Ahmed
Journal:  Front Cell Dev Biol       Date:  2021-03-08

Review 9.  Genomic alterations in gynecological malignancies: histotype-associated driver mutations, molecular subtyping schemes, and tumorigenic mechanisms.

Authors:  Seiichi Mori; Osamu Gotoh; Kazuma Kiyotani; Siew Kee Low
Journal:  J Hum Genet       Date:  2021-06-07       Impact factor: 3.172

10.  PAX8 lineage-driven T cell engaging antibody for the treatment of high-grade serous ovarian cancer.

Authors:  Emily Lee; Sarah Szvetecz; Ryan Polli; Angelo Grauel; Jayson Chen; Joyce Judge; Smita Jaiswal; Rie Maeda; Stephanie Schwartz; Bernd Voedisch; Mateusz Piksa; Chietara Japutra; Lingheswar Sadhasivam; Yiqin Wang; Ana Carrion; Sinan Isim; Jinsheng Liang; Thomas Nicholson; Hong Lei; Qing Fang; Michelle Steinkrauss; Dana Walker; Joel Wagner; Viviana Cremasco; Hui Qin Wang; Giorgio G Galli; Brian Granda; Keith Mansfield; Quincey Simmons; Andrew Anh Nguyen; Nicole Vincent Jordan
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.